DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Acetaminophen, Caffeine and Dihydrocodeine (Acetaminophen / Caffeine / Dihydrocodeine Bitartrate) - Summary

 
 



SUMMARY

Acetaminophen, Caffeine and Dihydrocodeine Bitartrate* Tablets CIII
.8 mg/60 mg/32 mg

Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Tablets are supplied in tablet form for oral administration.

Each tablet contains:

Acetaminophen..........................................................712.8 mg

Caffeine.....................................................................60 mg

Dihydrocodeine Bitartrate*..........................................32 mg

(*Warning: May be habit forming)

Acetaminophen (4'-hydroxyacetanilide), a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic.

Caffeine (1,3,7-trimethylxanthine), a bitter, white powder or white-glistening needles, is a central nervous system stimulant.

Dihydrocodeine bitartrate (4,5-Epoxy-3-methoxy-17-methylmorphinan-6-ol (+)-tartrate), an odorless, fine white powder is an opioid analgesic.

Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Tablets are indicated for the relief of moderate to moderately severe pain.


See all Acetaminophen, Caffeine and Dihydrocodeine indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Acetaminophen, Caffeine and Dihydrocodeine (Acetaminophen / Caffeine / Dihydrocodeine)

'Smoke alarm' one of 36 genes newly found to play role in pain sensation
Source: Genetics News From Medical News Today [2016.06.24]
Genes identified as affecting nerve sensitivity in fruit flies could represent future drug targets in human pain management.

Opioid Update: Painkiller Misuse in U.S. Doubled in Decade
Source: MedicineNet Drug Abuse Specialty [2016.06.24]
Title: Opioid Update: Painkiller Misuse in U.S. Doubled in Decade
Category: Health News
Created: 6/24/2016 12:00:00 AM
Last Editorial Review: 6/24/2016 12:00:00 AM

SPECT/CT Improves Back Pain Management
Source: Medscape Radiology Headlines [2016.06.22]
Treating chronic back pain can be complex, but SPECT/CT can help clinicians clearly identify the site of pain to improve the precision of nerve block injections, a new study suggests.
Medscape Medical News

Long-term opioids may not be best pain management option for all sickle cell patients
Source: Genetics News From Medical News Today [2016.06.22]
Small study shows some on opioids reported more pain, fatigue.In a small study looking at pain assessments in adults with sickle cell disease, researchers at Johns Hopkins says overall, those...

OTC Antacids Linked to Bleeding Risk: The Pain Medicine News Report
Source: MedPage Today Rheumatology [2016.06.22]
(MedPage Today) -- Also, new Hopkins program to diminish opioid overdose

more news >>

Clinical Trials Related to Acetaminophen, Caffeine and Dihydrocodeine (Acetaminophen / Caffeine / Dihydrocodeine)

Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine [Terminated]
The objective of this randomized, double blind study is to demonstrate that one dose oral "excedrin migraine" (acetaminophen, aspirin and caffeine) is not inferior when compared to one dose of intravenous prochlorperazine for the treatment of acute migraine headaches in the emergency department.

Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin [Completed]
Relacatib is being developed for the treatment of osteoporosis, osteoarthritis and possibly other bone disorders. Recent results suggest that relacatib interacts with the way our bodies metabolise drugs and so some drugs which are commonly prescribed to the intended target patient population could be affected by giving relacatib at the same time. The purpose of this study is to evaluate the effect of repeat dose administration of relacatib on the way subjects bodies metabolise three commonly prescribed medications in the osteoarthritis population: ibuprofen, acetaminophen, and atorvastatin.

Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine [Completed]
The main purpose of this study is to compare the efficacy and safety of aspirin, acetaminophen and caffeine (AAC) with sumatriptan and placebo in the acute treatment of migraine.

Efficacy and Safety Assessment of an Anti-Cold Preparation in the Symptomatic Treatment of Common Cold and Flu-Like Syndrome [Recruiting]

ACL Repair and Multimodal Analgesia [Recruiting]
This study will evaluate the effectiveness of an aggressive multimodal regimen versus standard multimodal for ACL repair using hamstring graft for patients having surgery in our outpatient surgicenter.

more trials >>


Page last updated: 2016-06-24

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015